{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:05Z","timestamp":1786119545456,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,26]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Multiple endocrine neoplasia type 1 (MEN1) syndrome is a rare and complicated disease that is associated with several endocrine tumors. Here, we report a case of MEN1 associated with insulinoma, parathyroid, and pituitary tumors by\n                      <jats:sup>68<\/jats:sup>\n                      Ga-DOTATATE positron emission tomography\/computed tomography (PET\/CT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 49-year-old woman presented with intermittent hypoglycemia for more than a year and developed indistinct consciousness without an apparent trigger.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Biochemical results showed abnormally high serum insulin and parathyroid hormone levels. She underwent an Abdominal magnetic resonance imaging revealed a small nodule in the uncinate process of the pancreas, but it did not clarify the nature of the small nodule. Pituitary magnetic resonance imaging scan revealed a micropituitary tumor, and parathyroid imaging showed no abnormalities.\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT showed no apparent abnormal\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG uptake in the whole body. In contrast,\n                      <jats:sup>68<\/jats:sup>\n                      Ga-DOTATATE PET\/CT imaging showed pathological radiotracer uptake in the pancreatic uncinate process, accompanied by mild radiotracer uptake in the pituitary gland, and no apparent abnormal radiotracer uptake in the parathyroid area.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent echoendoscopy for pancreatic uncinate process lesions and surgical resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Histological analysis was suggested of insulinoma of pancreatic neuroendocrine tumor, the Ki-67 index was low (only 1% being positive).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      This case demonstrates that\n                      <jats:sup>68<\/jats:sup>\n                      Ga-DOTATATE can be used for the detection of MEN1-related tumors and preoperative localization of small and low-grade insulinomas by PET\/CT.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000030252","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T10:01:15Z","timestamp":1661853675000},"page":"e30252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["68Ga-DOTATATE PET\/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report"],"prefix":"10.1097","volume":"101","author":[{"given":"Yunuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglian","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-09-0678","article-title":"Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.","volume":"69","author":"Gracanin","year":"2009","journal-title":"Cancer Res"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1148\/rg.2020200025","article-title":"Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification.","volume":"40","author":"Khanna","year":"2020","journal-title":"Radiographics"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-012-9631-1","article-title":"Diagnostic performance of gallium-68 somatostatin receptor PET and PET\/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.","volume":"42","author":"Treglia","year":"2012","journal-title":"Endocrine"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00259-009-1349-9","article-title":"68Ga-DOTA-NOC PET\/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours.","volume":"37","author":"Ambrosini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ejrad.2015.06.024","article-title":"Clinical value of 68Ga-DOTATATE-PET\/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET).","volume":"84","author":"Albanus","year":"2015","journal-title":"Eur J Radiol"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","article-title":"Update on multiple endocrine neoplasia Type 1 and 2.","volume":"47","author":"Al-Salameh","year":"2018","journal-title":"Presse Med"},{"key":"R8-20250707","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","article-title":"JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.","volume":"56","author":"Ito","year":"2021","journal-title":"J Gastroenterol"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2015-3766","article-title":"Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 study group.","volume":"101","author":"van Leeuwaarde","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltim)"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1148\/rg.2020200025","article-title":"Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification.","volume":"40","author":"Khanna","year":"2020","journal-title":"Radiographics"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAP.0000000000000201","article-title":"Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances.","volume":"26","author":"Guilmette","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1210\/jc.2018-02754","article-title":"68Ga-Exendin-4 PET\/CT Detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1.","volume":"104","author":"Antwi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/imj.15141","article-title":"Utility of 68Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemia.","volume":"51","author":"Kalff","year":"2021","journal-title":"Intern Med J"},{"key":"R16-20250707","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.14406","article-title":"Exendin-4-based imaging in insulinoma localization: systematic review and meta-analysis.","volume":"95","author":"Shah","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00259-012-2299-1","article-title":"Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc\/EDDA)NH2]-exendin-4 for the detection of insulinoma.","volume":"40","author":"Sowa-Staszczak","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12020-015-0702-y","article-title":"Role of 68Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1).","volume":"52","author":"Lastoria","year":"2016","journal-title":"Endocrine"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jamcollsurg.2015.04.005","article-title":"Results of 68gallium-DOTATATE PET\/CT scanning in patients with multiple endocrine neoplasia type 1.","volume":"221","author":"Sadowski","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R20-20250707","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00259-016-3331-7","article-title":"Role of 68ga somatostatin receptor PET\/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.","volume":"43","author":"Prasad","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-20250707","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2967\/jnumed.110.085142","article-title":"Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.","volume":"52","author":"Wild","year":"2011","journal-title":"J Nucl Med"},{"key":"R22-20250707","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-20250707","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2009-1082","article-title":"Glucagon-like peptide-1 receptor imaging for localization of insulinomas.","volume":"94","author":"Christ","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20250707","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.39.4.562","article-title":"Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.","volume":"39","author":"Zimmer","year":"1996","journal-title":"Gut"},{"key":"R25-20250707","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jc.2016-3445","article-title":"Localization of insulinoma using 68Ga-DOTATATE PET\/CT scan.","volume":"102","author":"Nockel","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20250707","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1210\/jc.2016-3865","article-title":"Utility of FDG-PET imaging for risk stratification of pancreatic neuroendocrine tumors in MEN1.","volume":"102","author":"Kornaczewski Jackson","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000030252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:24:23Z","timestamp":1786040663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000030252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":26,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030252","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}